PCN107 Cost-Effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for NON-SMALL CELL LUNG Cancer in Greece

Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.244
https://www.valueinhealthjournal.com/article/S1098-3015(20)32500-6/fulltext
Title : PCN107 Cost-Effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for NON-SMALL CELL LUNG Cancer in Greece
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32500-6&doi=10.1016/j.jval.2020.08.244
First page :
Section Title :
Open access? : No
Section Order : 10196
Categories :
Tags :
Regions :
ViH Article Tags :